作者：
Jennie B,Jarrett [1]
;
Jeffrey,Bratberg [2]
;
Anne L,Burns [3]
;
Gerald,Cochran [4]
;
Bethany A,DiPaula [5]
;
Anna,Legreid Dopp [6]
;
Abigail,Elmes [1]
;
Traci C,Green [7]
;
Lucas G,Hill [8]
;
Felicity,Homsted [9]
;
Stephanie L,Hsia [10]
;
Michele L,Matthews [11]
;
Udi E,Ghitza [12]
;
Li-Tzy,Wu [13]
;
Gavin,Bart [14]
作者单位：
Department of Pharmacy Practice, College of Pharmacy, University of Illinois Chicago, Chicago, USA.
[1]
Department of Pharmacy Practice and Clinical Research, College of Pharmacy, University of Rhode Island, Kingston, RI, USA.
[2]
American Pharmacists Association, Washington, DC, USA (retired).
[3]
Department of Internal Medicine, School of Medicine, University of Utah, Salt Lake City, UT, USA.
[4]
Department of Practice, Sciences, and Health Outcomes Research, School of Pharmacy, University of Maryland Baltimore, Baltimore, MD, USA.
[5]
American Society of Health-System Pharmacists, Washington, DC, USA.
[6]
COBER on Opioids and Overdose at Rhode Island Hospital and the Warren Alpert Medical School of Brown University, Providence, RI, USA.;Opioid Policy Research Collaborative, The Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USA.
[7]
The University of Texas at Austin, College of Pharmacy, Austin, TX, USA.
[8]
FQHC 340B Compliance, Inc., Lebanon, TN, USA.
[9]
Department of Clinical Pharmacy, San Francisco School of Pharmacy, University of California, San Francisco, CA, USA.
[10]
Department of Pharmacy Practice, School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences, Boston, MA, USA.
[11]
National Institute on Drug Abuse (NIDA), Center for the Clinical Trials Network (CCTN), Bethesda, MD, USA.
[12]
Duke University School of Medicine, Durham, NC, USA.
[13]
Department of Medicine, Hennepin Healthcare, Minneapolis, MN, USA.
[14]
DOI
10.1177/08897077231203849
PMID
37902032
发布时间
2024-10-31
换一批
换一批
